34682258|PMC8540212
{'Chemical', 'Disease', 'Species', 'Gene'}
Background: Since the novel coronavirus disease (COVID-19) outbreak, the cases of COVID-19 co-infections have been increasingly reported worldwide. Therefore, the patient received antimycotic treatment using LAmB with a dosage of 4 mg/kg/day, and she improved subsequently. The most commonly administered medication was amphotericin B (92.5%), followed by posaconazole (4.7%) and isavuconazole (3.7%).While the outcome of the two cases was not reported, 48.1% of the reported cases improved, 46.3% died, 5.6% remained unchanged Table 6.Despite the majority of CAM patients were males (74.4%), the incidence of mortality was not significantly different (Sig.